Flaxseed oil increases aortic reactivity to phenylephrine through reactive oxygen species and the cyclooxygenase-2 pathway in rats
© Nunes et al.; licensee BioMed Central Ltd. 2014
Received: 17 April 2014
Accepted: 23 June 2014
Published: 3 July 2014
Flaxseed oil has the highest concentration of omega-3 α-linolenic acid, which has been associated with cardiovascular benefit. However, the mechanism underlying the vascular effects induced through flaxseed oil is not well known. Thus, in the present study, we investigated the effects of flaxseed oil on vascular function in isolated rat aortic rings.
Wistar rats were treated daily with flaxseed oil or a control (mineral oil) intramuscular (i.m.) for fifteen days. Isolated aortic segments were used to evaluate cyclooxygenase-2 (COX-2) protein expression, superoxide anion levels and vascular reactivity experiments.
Flaxseed oil treatment increased the vasoconstrictor response of aortic rings to phenylephrine. Endothelium removal increased the response to phenylephrine in aortic segments isolated from both groups, but the effect was smaller in the treated group. L-NAME incubation similarly increased the phenylephrine response in segments from both groups. The TXA2 synthase inhibitor furegrelate, the selective COX-2 inhibitor NS 398, the TP receptor antagonist SQ 29.548, the reactive oxygen species (ROS) scavenger apocynin, the superoxide anion scavengers tiron and the phospholipase A2 inhibitor dexamethasone partially reversed the flaxseed oil-induced increase in reactivity to phenylephrine.
These findings suggest that flaxseed oil treatment increased vascular reactivity to phenylephrine through an increase in ROS production and COX-2-derived TXA2 production. The results obtained in the present study provide new insight into the effects of flaxseed oil treatment (i.m.) on vascular function.
KeywordsOmega-3 Flaxseed oil Aorta Vascular reactivity Oxidative stress
The consumption of flaxseed and its components has been associated with the prevention or reduction of cardiovascular disease. Flaxseed contains a mixture of fatty acids, primarily polyunsaturated fatty acids (PUFA), comprising 57% omega-3 α-linolenic acid (ALA), 16% omega-6 linoleic acid (LA) , and dietary fibers and phytoestrogen lignans .
The lignan in flaxseed possesses potent antioxidant effects , and PUFA have been associated with improvements in a variety of pathological conditions, such as myocardial infarction, atherosclerosis and hypertension [4–6]. Therefore, the cardiovascular effects of flaxseed could be attributed not only to PUFA, but also to the dietary fibers and phytoestrogen lignans presents in these grains. Previous reports concerning the vascular effect of flaxseed [7, 8] have not provided evidence on whether the cardiovascular effects of flaxseed could be attributed to the PUFA present in the oil or the lignans and fibers present in the seeds.
We previously demonstrated that treatment with soybean oil for 15 days increases left ventricular performance without affecting arterial blood pressure in rats . Considering the cardioprotective mechanisms induced through soybean oil , which is rich in LA, and other oils rich in PUFA, we investigated whether flaxseed oil treatment would produce vascular benefits. The effects of ALA on the cyclooxygenase-2 (COX-2) pathway have been shown to decrease thromboxane A2 (TXA2) and increase prostacyclin 3 (PGI3) in vessels, such as the aorta [10–12], which in turn, could augment endothelium-dependent vasodilatation. However, LA has been shown to increase series 2 prostaglandins and thromboxane, which increases vascular tone . However, there is limited evidence regarding the vascular effects of flaxseed oil, which is rich in PUFA, such as ALA. Thus, the primary aim of the present study was to investigate the effects of flaxseed oil treatment on endothelium-dependent vascular reactivity.
As ALA is highly susceptible to oxidation, flaxseed oil could also induce lipid peroxidation [14, 15], which might adversely effect the protection of the vascular system. Thus, a secondary aim of this study is to verify the influence of flaxseed oil treatment on reactive oxygen species (ROS) and COX-2 pathways.
The present study is the first to show that treatment (i.m.) with flaxseed oil for two weeks increases the contractile response induced through phenylephrine in the rat aorta. This response is endothelium-dependent, and most likely reflects an increase of COX-2-derived TXA2 and superoxide anion production.
Flaxseed oil has recently attracted much research attention, as this seed is one of the richest vegetable oil sources of ALA, associated with cardiovascular benefits, and has lower amounts of LA; these compounds are derived from the omega-3 (C18:3 n-3) and omega-6 (C18:2 n-6) families, respectively [4–6, 16].
Flaxseed oil contains n-3 ALA, a precursor molecule for the endogenous synthesis of f eicosapentaenoic acid (EPA) and docosapentaenoic acid (DHA) . LA, which is present in lower amounts in flaxseed oil, is a precursor molecule for the synthesis of arachidonic acid (AA) . Some reports have demonstrated that EPA and DHA prevent the development of hypertension [18, 19] and exhibit anti-atherothrombogenic effects . These effects might be induced, at least in part, through a decrease in TXA2 and an increase in PGI3 in vessels, such as the aorta [10–12]. Therefore, we investigated the effects of flaxseed oil treatment on endothelial modulation in the vascular responses induced through α-adrenoceptor activation in isolated aortic rings, as the aorta is a major artery susceptible to atherosclerosis.
In the present study, we observed increased vascular reactivity to phenylephrine in isolated aortic rings from flaxseed oil-treated rats. However, the treatment did not impair the endothelium-dependent relaxation induced through acetylcholine. Similarly, the vascular response to sodium nitroprusside was unaffected, suggesting that the endothelial-independent routes through which vascular relaxation is modulated were unaltered.
The effects of flaxseed on contractile and vasodilator responses are controversial. A previous report showed that feeding with a flaxseed-supplemented diet for 6, 8 or 16 weeks does not modify norepinephrine-induced vasoconstriction or the relaxation response induced through acetylcholine or sodium nitroprusside . However, other reports have shown that a high-flaxseed diet enhances endothelial vasorelaxant function without reducing blood pressure in hypertensive rats . Flaxseed is a rich source of plant lignans. The lignin secoisolariciresinol diglucoside in flaxseed possesses potent antioxidant effects . Therefore, the improved endothelial vasodilatation, as previously demonstrated , could reflect the activities of lignans. However, Ogawa et al.  demonstrated that spontaneously hypertensive rats (SHR) fed a diet containing 10% flaxseed oil for four weeks did not show altered endothelium-dependent aortic relaxation in response to acetylcholine, although a significantly lower systolic blood pressure was detected.
To investigate the role of the endothelium in the increased phenylephrine responses induced through flaxseed oil treatment in aortic rings, the experiments in the present study were performed in the absence of endothelium. Endothelium removal promoted an increase in the phenylephrine-induced contraction in both groups, but this effect was smaller in the aortic rings from treated rats, suggesting that flaxseed oil affects endothelial function. These results suggest that the ability of the endothelium to negatively modulate the contractile response induced by phenylephrine may be impaired in isolated aortic rings of flaxseed oil-treated rats.
The increased vascular reactivity to phenylephrine and concomitant reduction of endothelial modulation in the aortic rings of treated rats might reflect reduced NO bioavailability . Therefore, L-NAME was used to investigate the putative role of NO in the effects of flaxseed oil treatment on the contractile responses induced through phenylephrine. The results (Figure 3) showed that the phenylephrine responses were similar in the aortic rings of both control and treated rats, suggesting that the flaxseed oil treatment did not affect the endothelial-induced NO modulation of the vasoconstrictor response. The data concerning the effects of flaxseed oil on the nitric oxide pathway is limited and controversial. Sekine et al.  demonstrated that the oral administration of 1 mL flaxseed oil for 5 days reduces systolic blood pressure and increases prostaglandin I2 (PGI2) and NO release in SHR. However, Karaca and Eraslan  showed that 0.1 ml flaxseed oil administered through gavage for 30 days did not alter nitric oxide levels in the heart, brain and liver of rats.
Flaxseed oil is rich in ALA. ALA and LA are synthesized through a series of elongation and desaturation reactions and can subsequently be incorporated into cell membrane phospholipids . EPA, DHA and AA act as alternative substrates for both cyclooxygenase (COX) and lipoxygenase (LOX) enzyme complexes, generating series 3 prostaglandins and thromboxanes and series 5 leukotrienes (EPA + DHA) or series 2 prostaglandins and thromboxanes and series 4 leukotrienes (AA) . The series 2 prostaglandins and thromboxanes increase vascular tone. Therefore, to assess the participation of these compounds, we used indomethacin to assess whether vasoconstrictor prostanoids are involved in the increased vascular reactivity to phenylephrine induced through flaxseed oil treatment. Indomethacin reduced the response to phenylephrine in aortic segments from both groups, but this reduction was greater in the aortic rings of flaxseed oil-treated rats, suggesting the increased participation of the COX pathway. Moreover, NS 398, SQ 29.548 and furegrelate reduced the vasoconstrictor responses to phenylephrine in aortic segments from treated rats, suggesting that vasoconstrictor prostanoids, specifically TXA2, increase reactivity to phenylephrine induced through flaxseed oil treatment. Consistent with these results, we also observed that COX-2 protein expression was greater in flaxseed oil-treated rats than in control rats.
Tou et al.  demonstrated that female rats fed a diet supplemented with flaxseed oil for 8 weeks showed decreased liver AA, and no significant differences in the series 2 eicosanoids, PGE2 and TXB2 metabolites were observed. However, Lee et al.  showed that the aortic production of PGI2 and the serum concentration of TXA2 were significantly low in rats fed a diet containing flaxseed oil for 4 weeks. However, Rupp et al.  showed an increased production of 6-keto-PGFlα, a PGI2 by-product, in rats fed a diet supplemented with flaxseed oil, although the arachidonic acid content was greatly reduced. Sekine et al.  reported similar results, showing that the plasma 6-keto-PGFlα levels were significantly higher in the fed flaxseed oil diet group.
PGI2 is synthesized in response to the release of the n-6 fatty acid AA from membrane phospholipids . However, in addition to the increased PGI2, the n-6 LA could also increase other series 2 prostanoids, such as TXA2, a potent vasoconstrictor . Moreover, a previous report demonstrated that high levels of PGI2 could induce a vasoconstrictor response through the activation of the TP receptor . Although we did not measure levels of PGI2 in the present study, this hypothesis cannot be discarded.
Moreover, eicosanoids derived from PUFA, such as AA and EPA, are physiologically active compounds that act locally as signaling molecules through G protein-linked receptors. When AA is predominantly incorporated into cell membrane phospholipids under conditions, such as injury or inflammation, phospholipase A2 might release AA. Subsequently, intracellular signaling cascades might elicit a wide range of responses, including vasoconstriction, the activation of leukocytes, the stimulation of platelet aggregation and the generation of reactive oxygen species . These effects might increase vulnerability to endothelial dysfunction and induce inflammation in the vessel wall, which is a key factor in atherosclerosis .
Thus, we suggest that the increased TXA2 induced through flaxseed oil treatment (i.m.) might increase phenylephrine contractions, as observed in the present study, through n-6 LA. Alterations in the eicosanoid profile might have important effects on inflammation . The n-3 and n-6 PUFA compete for COX and LOX enzymes. Moreover, the series 2 and series 4 eicosanoids derived from n-6 PUFA are more biologically active than the series 3 and series 5 eicosanoids derived from n-3 PUFA , even when present in smaller amounts . Furthermore, series 2 and series 4 eicosanoids can induce pro-inflammatory and pro-aggregatory states , likely promoting increased vascular reactivity .
Therefore, we used the phospholipase A2 blocker, dexamethasone, to investigate whether phospholipase A2 mediates the effects induced through flaxseed oil treatment in vascular reactivity. Dexamethasone abolished the effects of flaxseed oil on the contractile response to the α1-agonist, suggesting that a 15-day flaxseed oil treatment could increase phospholipase A2 activity, which in turn, increases eicosanoid production, leading to increased series 2 and series 4 eicosanoid activity. The effect of dexamethasone could be mediated through a reduction of COX-2-derived TXA2 release in response to α-adrenergic activation, as previously reported .
Glucocorticoids play an important role in the control of vascular smooth muscle tone through the modification of vasoconstrictor responses to different vasoactive agents and through alterations in vascular prostanoid and/or nitric oxide production [36, 37]. Therefore, dexamethasone could inhibit COX-2 in the isolated aortic rings of flaxseed oil-treated rats, normalizing vascular reactivity to the control group level. In addition to COX-2-derived products, the increased oxidative stress could also promote vascular hyperreactivity and endothelial dysfunction in aortic rings isolated from treated rats. The results demonstrated that apocynin, a ROS scavenger, and tiron, a cell permeant non-enzymatic scavenger of O2.–, decreased vascular reactivity to phenylephrine in aortic rings isolated from treated rats, suggesting that flaxseed oil exposure increases ROS, primarily O2.–, and induces oxidative stress.
Consistent with these findings, we observed an increase of local superoxide anion production in the aortic rings from flaxseed oil-treated rats. However, incubation with catalase did not alter the vascular contractile responses in both groups, suggesting that flaxseed oil treatment did not affect the release of hydrogen peroxide. Martínez-Revelles et al.  demonstrated that COX-2-derived products modulate ROS production and also, ROS can activate COX expression. Thus, we suggest that COX-2 prostanoids might increase ROS production and ROS might act on COX-2 expression, although these COX-2-derived products and ROS could operate independently.
However, to investigate whether the flaxseed oil treatment could induce an inflammatory state, we evaluated serum C-reactive protein levels. Our results demonstrated that the flaxseed treatment did not modify this parameter. Flaxseed oil has variable effects on the inflammatory mediators that seem to be dose- and time- dependent. Lower doses do not affect TNF-a, IL-1b, IL-6, or soluble intracellular adhesion molecule-1 (sICAM-1) in healthy adults . However, higher concentrations of flaxseed oil decrease the levels of cytokines . Moreover, 4 months of flaxseed oil supplementation appears to reduce the C-reactive protein levels .
A previous report demonstrated that flaxseed oil treatment increases lipid peroxidation and oxidative stress and reduces SOD activity . Another report showed that flaxseed oil does not affect catalase activity or superoxide dismutase in monkey livers in vivo and in vitro. Although we did not measure SOD activity, these results suggest that flaxseed oil treatment increased ROS production, primarily the superoxide anion, without increasing hydrogen peroxide.
However, although the present study demonstrated increased ROS production, a recent study showed that the combined effect of flaxseed oil and astaxanthin, a natural antioxidant, in rats fed a high-fat diet efficiently ameliorates oxidative stress, lipid profile and inflammation .
However, as mentioned above, flaxseed oil was also reported to promote and increase lipid peroxidation . Consistently, Nestel et al.  demonstrated that ALA reduces HDL and increases LDL plasmatic levels, likely reflecting high intake of ALA and increased vulnerability of polyunsaturated fatty acids to oxidation. This effect might alter the negative modulation of vascular tone in the endothelium, as shown in the present study.
In conclusion, the present study demonstrated that flaxseed oil treatment increases the vascular reactivity to phenylephrine and is associated with increased ROS production and the increased participation of COX-2 derivatives. Moreover, this treatment could increase phospholipase A2 participation, which in turn could increase the production of COX-2 inflammatory derivatives. Thus, the results of the present study provide new insights into the effects of flaxseed oil on vascular function.
Materials and methods
Animals and treatment
Male Wistar rats (250–300 g) were used in this study. The care and use of laboratory animals were in accordance with the Guide for the Care and Use of Laboratory Animals, and the protocols were approved through the Ethics Committee of the Federal University of Espirito Santo (038/2012 CEUA-UFES). During treatment, the rats were provided free access to tap water and fed standard chow ad libitum.
The rats were divided in two groups: flaxseed oil treatment or control. The treated group received a daily dose of 0.1 mL intramuscular (i.m.) of flaxseed oil for two weeks , and the control group received the same amount of mineral oil for the same time period. Notably, we used i.m. flaxseed oil injections to ensure that all rats received the same daily dose.
At the end of the treatment, the rats were anesthetized with urethane (1.2 g/kg, ip). The serum samples were collected and stored at −80°C until they were used to assess C-reactive protein. The thoracic aortas were carefully dissected, and the connective tissue was removed. For vascular reactivity experiments, the aortas were divided into cylindrical segments of 4 mm in length. To analyze the expression of COX-2 isoforms and evaluate O2.– production in situ, the aortic segments were frozen at −80°C until the day of analysis.
Vascular reactivity measurements
The aortic segments, 4 mm in length, were mounted in an organ bath at 37°C containing 5 mL Krebs-Henseleit solution (in mM: NaCl 118, KCl 4.7, NaHCO3 25, CaCl2-2H2O 2.5, KH2PO4 1.2, MgSO4–7H2O 1.2, glucose 11 and ethylenediamine-tetraacetic acid (EDTA) 0.01), continuously gassed with a 95% O2-5% CO2 mixture (pH 7.4). The arterial segments were stretched to an optimal resting tension of 1 g. The isometric tension was recorded using a force transducer (TSD125C, BIOPAC Systems, Santa Barbara, CA, USA) connected to an acquisition system (MP100, BIOPAC Systems).
After a 45-min equilibration period, all aortic rings were exposed twice to 75 mM KCl (30 min each), to examine the functional integrity of the samples and assess the maximal induced tension. Subsequently, the endothelial integrity was examined using acetylcholine (10 μM) on segments previously treated with phenylephrine (1 μM). A relaxation equal to or greater than 90% was indicative of functional integrity in the endothelium. After a washout period (30 min), increasing concentrations of phenylephrine (0.1 nM to 0.3 mM) were applied. A concentration-response curve to this agonist was obtained, and the maximal tension was measured upon reaching a plateau.
The influence of the endothelium on the response to phenylephrine was examined through the mechanistic removal of the tissue (rubbing the lumen with a needle). The absence of endothelium was confirmed based on the inability of 10 μM of acetylcholine to produce relaxation, and the functional integrity of the vessel was evaluated through KCl contraction. When the integrity of the vessel was damaged, the rings were discarded. The role of endothelium-derived vasoactive factors in the phenylephrine-elicited contractile response was examined. The effects of the following drugs were evaluated: the nonspecific NOS inhibitor N-nitro-L-arginine methyl ester (L-NAME, 100 μM), an inhibitor phospholipase A2 (dexamethasone, 1 μM), a non-selective cyclooxygenase inhibitor (indomethacin, 10 μM), a COX-2 inhibitor (NS 398, 1 μM), a TP receptor antagonist (SQ 29.548, 1 μM), a TXA2 synthase inhibitor (furegrelate, 1 μM), a ROS scavenger (apocynin, 10 μM), a superoxide anion scavenger (tiron, 1 mM) and a hydrogen peroxide scavenger (catalase, 1000 U.mL−1). These drugs were added at 30 min prior to the generation of phenylephrine concentration-response curves.
In another set of experiments, following the 45-min equilibration period, aortic rings were treated with phenylephrine (1 μM) until a plateau was reached (approximately 15 min), and concentration-response curves to acetylcholine (0.01 nM to 30 μM) or sodium nitroprusside (0.01 nM to 30 μM) were obtained for both groups.
In situ detection of vascular O2.– production
The oxidative fluorescent dye dihydroethidium (DHE) was used to evaluate O2.–production in situ, as previously described . Hydroethidine freely permeates cells, and in the presence of O2.–, this compound is oxidized to ethidium bromide, which is trapped through DNA intercalation. Ethidium bromide is excited at 546 nm and emits light at 610 nm. The frozen tissue segments were dissected into 10-μm-thick sections and placed on a glass slide. The serial sections were equilibrated under identical conditions for 30 min at 37°C in Krebs-HEPES buffer (in mM: 130 NaCl, 5.6 KCl, 2 CaCl2, 0.24 MgCl2, 8.3 HEPES, and 11 glucose, pH 7.4). Fresh buffer containing DHE (2 μM) was applied topically to each tissue section. Subsequently, the sections were coverslipped and incubated for 30 min in a light-protected humidified chamber at 37°C, followed by imaging using an inverted fluorescence microscope Leica DM 2500 with a 40× objective and a Leica DFC 310 FX camera, using the same imaging settings for control and flaxseed oil-treated samples. The fluorescence was detected using a 568-nm long-pass filter. For quantification, eight frozen tissue segments per animal were sampled for each experimental condition and averaged. The mean fluorescence densities in the target region were calculated using ImageJ software.
Western blot analysis of COX-2 expression
COX-2 protein expression was detected in homogenates from the aortic segments of control and flaxseed oil-treated rats, as previously described . The proteins in the homogenates were separated through 10% SDS-PAGE and subsequently transferred to nitrocellulose membranes, followed by incubation with mouse monoclonal antibodies for COX-2 (1:200; Cayman Chemical; Ann Arbor, MI, USA). After washing, the membranes were incubated with an anti-mouse immunoglobulin antibody conjugated to horseradish peroxidase (1:5000, StressGen, Victoria, Canada). After thorough washing, the immunocomplexes were detected using an enhanced horseradish peroxidase/luminal chemiluminescence system (ECL Plus, Amersham International, Little Chalfont, UK) and film (Hyperfilm ECL - International). The signals on the immunoblot were quantified using the National Institutes of Health Image V1.56 software. The same membrane was used to detect β-actin expression using a mouse monoclonal antibody (1:5000, Sigma, USA).
Measurement of C-reactive protein
The C-reactive protein concentrations were measured in serum simples by turbidimetry (Integra 4000), after immunoprecipitation with RCPLX (Roche/Hitachi cobas c) at the University Hospital Cassiano Antônio Moraes.
The vasoconstrictor responses induced through phenylephrine were normalized to the contraction induced through 75 mM KCl and expressed as a percentage of this contraction. The vasodilator responses are expressed as a percentage of the previous phenylephrine contraction. For each concentration-response curve, the maximum effect (Rmax) and the concentration of the agonist that produced one-half of the Rmax (EC50) were calculated using nonlinear regression analysis (GraphPad Prism Software, San Diego, CA). The sensitivity of the agonists is expressed as pD2 (−log EC50). To compare the effects of L-NAME, indomethacin and endothelium denudation on the contractile response to phenylephrine, the differences in the area under the concentration-response curves (dAUC) for phenylephrine under control and experimental conditions were calculated. The AUCs were calculated from the individual curve plots (GraphPad Prism Software), and the differences are expressed as the percentage of the AUC for the corresponding control. These values indicate differences in the magnitude of the effect of each treatment in the control and flaxseed oil-treated rats. The results are expressed as the means ± SEM of the number of rats studied, and the differences were analyzed using Student’s t-test and two-way ANOVA for comparisons between groups. When ANOVA showed a significant treatment effect, Bonferroni’s post hoc-test was used to compare individual means. Differences were considered statistically significant at P-values < 0.05.
Drugs and reagents
Flaxseed oil and dexamethasone were purchased from Cacalia Comercial Ltda (natural products) and Alquimia Compounding Pharmacy, respectively. L-NAME, 1-phenylephrine hydrochloride, indomethacin, NS 398, SQ 29.548, furegrelate, acetylcholine chloride, sodium nitroprusside, apocynin, tiron and catalase were purchased from Sigma-Aldrich (St. Louis, USA). All salts and reagents were analytical grade and obtained from Sigma-Aldrich or Merck (Darmstadt, Germany).
Polyunsaturated fatty acids
Spontaneously hypertensive rats
Reactive oxygen species
Nitric oxide synthase
N-nitro-L-arginine methyl ester
Sensitivity (concentration of the agonist that produced one-half of the Rmax)
This work was financially supported though CAPES and CNPq/FAPES (54668662/2011), Brazil. The authors would like to thank Jonaina Fiorim and Thaís de Oliveira Faria for assistance with the in situ detection of vascular O2.– production and western blot analysis of COX-2 expression, respectively.
This work was financially supported through funding from CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior) and CNPq/FAPES (Conselho Nacional de Desenvolvimento Científico e Tecnológico and Fundação de Amparo à Pesquisa do Espírito Santo) (54668662/2011). The funders had no role the in study design, data collection and analysis, decision to publish or preparation of the manuscript.
- Morris DH: Flax: A health and nutrition primer. Winnipeg: Flax Council of Canada. 2003, 3: 1-106.Google Scholar
- Prasad K: Flaxseed and cardiovascular health. J Cardiovasc Pharmacol. 2009, 54: 369-377. 10.1097/FJC.0b013e3181af04e5View ArticlePubMedGoogle Scholar
- Prasad K: Flaxseed: a source of hypocholesterolemic and antiatherogenic agents. Drug News Perspect. 2000, 13: 99-104. 10.1358/dnp.2000.13.2.662239View ArticlePubMedGoogle Scholar
- Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ: Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis. 2008, 197: 12-24. 10.1016/j.atherosclerosis.2007.11.008View ArticlePubMedGoogle Scholar
- Goodfellow J, Bellamy MF, Ramsey MW, Jones CJ, Lewis MJ: Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol. 2000, 35: 265-270. 10.1016/S0735-1097(99)00548-3View ArticlePubMedGoogle Scholar
- Von Schacky C: The role of omega-3 fatty acids in cardiovascular disease. Curr Atheroscler Rep. 2003, 5: 139-145. 10.1007/s11883-003-0086-yView ArticlePubMedGoogle Scholar
- Dupasquier CMC, Weber A-M, Ander BP, Rampersad PP, Steigerwald S, Wigle JT, Mitchell RW, Kroeger EA, Gilchrist JSC, Moghadasian MM, Lukas A, Pierce GN: Effects of dietary flaxseed on vascular contractile function and atherosclerosis during prolonged hypercholesterolemia in rabbits. Am J Physiol Heart Circ Physiol. 2006, 291: H2987-H2996. 10.1152/ajpheart.01179.2005View ArticlePubMedGoogle Scholar
- Talom RT, Judd SA, McIntosh DD, McNeill JR: High flaxseed (linseed) diet restores endothelial function in the mesenteric arterial bed of spontaneously hypertensive rats. Life Sci. 1999, 64: 1415-1425. 10.1016/S0024-3205(99)00075-2View ArticlePubMedGoogle Scholar
- Ribeiro Junior RF, Fernandes AA, Meira EF, Batista PR, Siman FDM, Vassallo DV, Padilha AS, Stefanon I: Soybean oil increases SERCA2a expression and left ventricular contractility in rats without change in arterial blood pressure. Lipids Health Dis. 2010, 9: 53- 10.1186/1476-511X-9-53View ArticlePubMedGoogle Scholar
- Rupp H, Turcani M, Ohkubo T, Maisch B, Brilla CG: Dietary linolenic acid-mediated increase in vascular prostacyclin formation. Mol Cell Biochem. 1996, 162: 59-64.View ArticlePubMedGoogle Scholar
- DeCaterina R, Giannessi D, Mazzone A, Bernini W, Lazzerini G, Maffei S, Cerri M, Salvatore L, Weksler B: Vascular prostacyclin is increased in patients ingesting omega-3 polyunsaturated fatty acids before coronary artery bypass graft surgery. Circulation. 1990, 82: 428-438. 10.1161/01.CIR.82.2.428View ArticlePubMedGoogle Scholar
- Kinsella J, Lokesh B, Stone R: Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am J Clin Nutr. 1990, 52: 1-28.PubMedGoogle Scholar
- Narumiya S, Sugimoto Y, Ushikubi F: Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999, 79: 1193-1226.PubMedGoogle Scholar
- Nestel PJ, Pomeroy SE, Sasahara T, Yamashita T, Liang YL, Dart AM, Jennings GL, Abbey M, Cameron JD: Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL oxidizability. Arterioscler Thromb Vasc Biol. 1997, 17: 1163-1170. 10.1161/01.ATV.17.6.1163View ArticlePubMedGoogle Scholar
- Trebušak T, Levart A, Voljč M, Tomažin U, Pirman T: The effect of linseed oil supplementation on performance, fatty acid composition and oxidative status of rabbits. Acta Agriculturae Slov. 2011, 98: 119-125.Google Scholar
- Harper CR, Edwards MJ, DeFilippis AP, DeFilipis AP, Jacobson TA: Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans. J Nutr. 2006, 136: 83-87.PubMedGoogle Scholar
- Barceló-Coblijn G, Murphy EJ: Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res. 2009, 48: 355-374. 10.1016/j.plipres.2009.07.002View ArticlePubMedGoogle Scholar
- Engler MB, Engler MM, Ursell PC: Vasorelaxant properties of n-3 polyunsaturated fatty acids in aortas from spontaneously hypertensive and normotensive rats. J Cardiovasc Risk. 1994, 1: 75-80. 10.1097/00043798-199406000-00012View ArticlePubMedGoogle Scholar
- Chen HW, Lii CK, Chen WT, Wang ML, Ou CC: Blood pressure-lowering effect of fish oil is independent of thromboxane A2 level in spontaneously hypertensive rats. Prostaglandins Leukot Essent Fatty Acids. 1996, 54: 147-154. 10.1016/S0952-3278(96)90072-1View ArticlePubMedGoogle Scholar
- Robinson JG, Stone NJ: Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. Am J Cardiol. 2006, 98: 39i-49i.View ArticlePubMedGoogle Scholar
- Ogawa A, Suzuki Y, Aoyama T, Takeuchi H: Effect of dietary alpha-linolenic acid on vascular reactivity in aorta of spontaneously hypertensive rats. J Oleo Sci. 2009, 58: 221-225. 10.5650/jos.58.221View ArticlePubMedGoogle Scholar
- Vanhoutte PM, Shimokawa H, Tang EHC, Feletou M: Endothelial dysfunction and vascular disease. Acta Physiol (Oxf). 2009, 196: 193-222. 10.1111/j.1748-1716.2009.01964.xView ArticleGoogle Scholar
- Sekine S, Sasanuki S, Aoyama T, Takeuchi H: Lowering systolic blood pressure and increases in vasodilator levels in SHR with oral alpha-linolenic acid administration. J Oleo Sci. 2007, 56: 341-345. 10.5650/jos.56.341View ArticlePubMedGoogle Scholar
- Karaca S, Eraslan G: The effects of flaxseed oil on cadmium-induced oxidative stress in rats. Biol Trace Elem Res. 2013, 155: 423-430. 10.1007/s12011-013-9804-7View ArticlePubMedGoogle Scholar
- Abeywardena MY, Head RJ: Longchain n-3 polyunsaturated fatty acids and blood vessel function. Cardiovasc Res. 2001, 52: 361-371. 10.1016/S0008-6363(01)00406-0View ArticlePubMedGoogle Scholar
- Tou JC, Altman SN, Gigliotti JC, Benedito VA, Cordonier EL: Different sources of omega-3 polyunsaturated fatty acids affects apparent digestibility, tissue deposition, and tissue oxidative stability in growing female rats. Lipids Health Dis. 2011, 10: 179- 10.1186/1476-511X-10-179PubMed CentralView ArticlePubMedGoogle Scholar
- Lee JH, Sugano M, Ide T: Effects of various combinations of omega 3 and omega 6 polyunsaturated fats with saturated fat on serum lipid levels and eicosanoid production in rats. J Nutr Sci Vitaminol (Tokyo). 1988, 34: 117-129. 10.3177/jnsv.34.117View ArticleGoogle Scholar
- Xavier FE, Blanco-Rivero J, Ferrer M, Balfagón G: Endothelium modulates vasoconstrictor response to prostaglandin I2 in rat mesenteric resistance arteries: interaction between EP1 and TP receptors. Br J Pharmacol. 2009, 158: 1787-1795. 10.1111/j.1476-5381.2009.00459.xPubMed CentralView ArticlePubMedGoogle Scholar
- Adkins Y, Kelley DS: Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem. 2010, 21: 781-792. 10.1016/j.jnutbio.2009.12.004View ArticlePubMedGoogle Scholar
- Libby P: The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med. 2008, 263: 517-527. 10.1111/j.1365-2796.2008.01965.xPubMed CentralView ArticlePubMedGoogle Scholar
- Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB: Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation. 2003, 108: 155-1560. 10.1161/01.CIR.0000079224.46084.C2View ArticlePubMedGoogle Scholar
- Ander BP, Dupasquier CM, Prociuk MA, Pierce GN: Polyunsaturated fatty acids and their effects on cardiovascular disease. Exp Clin Cardiol. 2003, 8: 164-172.PubMed CentralPubMedGoogle Scholar
- Simopoulos AP: Human requirement for N-3 polyunsaturated fatty acids. Poult Sci. 2000, 79: 961-970. 10.1093/ps/79.7.961View ArticlePubMedGoogle Scholar
- DeFilippis AP, Sperling LS: Understanding omega-3′s. Am Heart J. 2006, 151: 564-570. 10.1016/j.ahj.2005.03.051View ArticlePubMedGoogle Scholar
- Aras-Lopéz R, Blanco-Rivero J, Xavier FE, Salaices M, Ferrer M, Balfagón G: Dexamethasone decreases contraction to electrical field stimulation in mesenteric arteries from spontaneously hypertensive rats through decreases in thromboxane A2 release. J Pharmacol Exp Ther. 2007, 322: 1129-1136. 10.1124/jpet.107.123596View ArticlePubMedGoogle Scholar
- Ullian ME: The role of corticosteriods in the regulation of vascular tone. Cardiovasc Res. 1999, 41: 55-64. 10.1016/S0008-6363(98)00230-2View ArticlePubMedGoogle Scholar
- Yang S, Zhang L: Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol. 2004, 2: 1-12. 10.2174/1570161043476483View ArticlePubMedGoogle Scholar
- Martínez-Revelles S, Avendaño MS, García-Redondo AB, Alvarez Y, Aguado A, Pérez-Girón JV, García-Redondo L, Esteban V, Redondo JM, Alonso MJ, Briones AM, Salaices M: Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension. Antioxid Redox Signal. 2013, 18: 51-65. 10.1089/ars.2011.4335View ArticlePubMedGoogle Scholar
- Thies F, Miles EA, Nebe-von-Caron G, Powell JR, Hurst TL, Newsholme EA, Calder PC: Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids. 2001, 36: 1183-1193. 10.1007/s11745-001-0831-4View ArticlePubMedGoogle Scholar
- Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ: The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr. 1996, 63: 116-122.PubMedGoogle Scholar
- Lemos JRN, Alencastro MG D, Konrath AV, Cargnin M, Manfro RC: Flaxseed oil supplementation decreases C-reactive protein levels in chronic hemodialysis patients. Nutr Res. 2012, 32: 921-927. 10.1016/j.nutres.2012.08.007View ArticlePubMedGoogle Scholar
- L’Abbé MR, Trick KD, Beare-Rogers JL: Dietary (n-3) fatty acids affect rat heart, liver and aorta protective enzyme activities and lipid peroxidation. J Nutr. 1991, 121: 1331-1340.PubMedGoogle Scholar
- Kaasgaard SG, Hølmer G, Høy CE, Behrens WA, Beare-Rogers JL: Effects of dietary linseed oil and marine oil on lipid peroxidation in monkey liver in vivo and in vitro. Lipids. 1992, 27: 740-745. 10.1007/BF02535843View ArticlePubMedGoogle Scholar
- Xu J, Gao H, Zhang L, Chen C, Yang W, Deng Q, Huang Q, Huang F: A combination of flaxseed oil and astaxanthin alleviates atherosclerosis risk factors in high fat diet fed rats. Lipids Health Dis. 2014, 13: 63- 10.1186/1476-511X-13-63PubMed CentralView ArticlePubMedGoogle Scholar
- Wiggers GA, Peçanha FM, Briones AM, Pérez-Girón JV, Miguel M, Vassallo DV, Cachofeiro V, Alonso MJ, Salaices M: Low mercury concentrations cause oxidative stress and endothelial dysfunction in conductance and resistance arteries. Am J Physiol Heart Circ Physiol. 2008, 295: H1033-H1043. 10.1152/ajpheart.00430.2008View ArticlePubMedGoogle Scholar
- Alvarez Y, Pérez-Girón JV, Hernanz R, Briones AM, García-Redondo A, Beltrán A, Alonso MJ, Salaices M: Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats. J Pharmacol Exp Ther. 2007, 321: 381-388. 10.1124/jpet.106.115287View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.